Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 200
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic Access for Veterans
Ibogaine – The Promise, the Protocol, and Protecting the Sacred
Pα+ Psychedelic Bulletin #195: Psychedelics Namechecked in Trump Cabinet Meeting; Noma Therapy Aims to Disrupt At-Home Ketamine; Christian Angermayer on the Politics and Business...
“Neuropharmacology: Psychedelics on the Brain” – Jim Harris, Rachel Zoeller, DPT, David W. Mcmillan, Ph.D., and Manesh Girn, Ph.D.
March & April 2025 Psychedelic Patent Update: Lykos’ Patent Woes Continue; Filings Provide First Look at Seaport’s 2-Bromo-LSD Program; Delix’s Ergoline Analogues; CaaMTech’s Spinout
Tryp Therapeutics Announces Collaboration with Researchers at the University of Wisconsin-Madison
MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary...
Psygen Announces use of Psilocybin in Human Trial and Provides Update...
Mydecine Completes Spin-Out of U.S. Cannabis Assets
PharmaTher Initiates Phase 2 Clinical Trial of Ketamine for the Treatment...
Lobe Announces Krysalis VX Innovations Inc., a Company Equally Owned by...
Psychedelics and Perception Part 2: The First Era of Research
Anima Mundi: Psychedelics and The Ensouled Earth
Mydecine To Supply Lead Drug Candidate, MYCO-001, for Multi-Site NIDA Grant-Funded...
MindMed Announces Strategic Research Collaboration with Sphere Health
1
...
199
200
201
...
286
Page 200 of 286
